Congenital Abnormalities D000013

Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Congenital Abnormalities

Description

Malformations of organs or body parts during development in utero.   MeSH

Subtype Terms (20)

Abnormalities, Drug-Induced
4 drugs (3 approved, 1 experimental)

Abnormalities, Multiple
 

Abnormalities, Radiation-Induced
1 experimental drug

Abnormalities, Severe Teratoid
 

Aicardi Syndrome
5 approved drugs

Cardiovascular Abnormalities
22 drugs (15 approved, 7 experimental)

Chromosome Disorders
3 approved drugs

Congenital Microtia
4 drugs (2 approved, 2 experimental)

Digestive System Abnormalities
 

Eye Abnormalities
 

Hernias, Diaphragmatic, Congenital
4 drugs (3 approved, 1 experimental)

Lymphatic Abnormalities
 

Musculoskeletal Abnormalities
2 approved drugs

Nervous System Malformations
4 approved drugs

Respiratory System Abnormalities
2 approved drugs

Situs Inversus
 

Skin Abnormalities
9 drugs (2 approved, 7 experimental)

Stomatognathic System Abnormalities
 

Thyroid Dysgenesis
 

Urogenital Abnormalities
3 drugs (2 approved, 1 experimental)


Phase 3 Indicated Drugs (2)

Phase 2 Indicated Drugs (1)


Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.